140 related articles for article (PubMed ID: 34571211)
1. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
2. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
3. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
5. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
6. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
[TBL] [Abstract][Full Text] [Related]
7. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
[TBL] [Abstract][Full Text] [Related]
10. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
11. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.
Reddy OL; Sall MT; Dinh A; Cai Y; Ongkeko M; Arya N; Wilder J; Tran M; Jin P; Stroncek DF; Panch SR
Transfusion; 2023 Apr; 63(4):774-781. PubMed ID: 36975826
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
[TBL] [Abstract][Full Text] [Related]
13. Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Bankova AK; Caveney J; Yao B; Ramos TL; Bögeholz J; Heydari K; Diaz N; Jackson ML; Lowsky R; Brown JW; Johnston L; Rezvani AR; Frank MJ; Muffly L; Weng WK; Sidana S; Negrin RS; Miklos DB; Shiraz P; Meyer EH; Shizuru JA; Arai S
Transplant Cell Ther; 2022 Apr; 28(4):215.e1-215.e10. PubMed ID: 35042013
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal.
Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L
Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867
[TBL] [Abstract][Full Text] [Related]
16. Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J
Biol Blood Marrow Transplant; 2017 Jan; 23(1):147-152. PubMed ID: 27717872
[TBL] [Abstract][Full Text] [Related]
17. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.
Thibodeaux SR; Coble D; Day V; Fontaine MJ; Gabelli M; Gardiner N; Geach T; Schwartz J; Vasovic LV; Wyre R; Girdlestone J;
Transfusion; 2023 Apr; 63(4):782-790. PubMed ID: 36924403
[TBL] [Abstract][Full Text] [Related]
18. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.
Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G
Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044
[TBL] [Abstract][Full Text] [Related]
19. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
Mengling T; Rall G; Bernas SN; Astreou N; Bochert S; Boelk T; Buk D; Burkard K; Endert D; Gnant K; Hildebrand S; Köksaldi H; Petit I; Sauter J; Seitz S; Stolze J; Weber K; Weber M; Lange V; Pingel J; Platz A; Schäfer T; Schetelig J; Wienand E; Geist S; Neujahr E; Schmidt AH
Bone Marrow Transplant; 2021 Apr; 56(4):798-806. PubMed ID: 33219340
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Othman J; Aarons D; Bajel A; Butler J; Doocey R; O'Brien T; Purtill D; Smith L; Wilcox L; Hamad N
Intern Med J; 2023 Mar; 53(3):323-329. PubMed ID: 35833788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
